• Hướng dẫn cấu hình HOME WIFI VIETTEL

发布时间：2024-07-12

• 高清正版 JGJ∕T 253

发布时间：2024-07-12

• The effect of oral N

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/10968500The effect of oral N-acetylcysteine in chronic bronchitis: a ...网页In conclusion, with treatment periods of approximately 12-24 weeks, oral N-acetylcysteine reduces the risk of exacerbations and improves symptoms in patients with chronic bronchitis compared with placebo, without increasing the risk of adverse effects. Whether this benefit is sufficient to justify the routine and long-term use of N ...

发布时间：2024-07-12

• N

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/21429549N-linked glycosylation of dengue virus NS1 protein …网页2011年5月10日 · Dengue virus (DENV) NS1 is a versatile non-structural glycoprotein that is secreted as a hexamer, binds to the cell surface of infected and uninfected cells, and has immune evasive functions. DENV NS1 displays two conserved N-linked glycans at N130 and N207. In this study, we examined the role of th …

发布时间：2024-07-12

• IP Address Lookup

发布时间：2024-07-12

• FTBMT a Novel and Selective GPR52 Agonist Demonstrates

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/28851764FTBMT, a Novel and Selective GPR52 Agonist, Demonstrates ... - PubMed网页GPR52 is a Gs-coupled G protein-coupled receptor that is predominantly expressed in the striatum and nucleus accumbens (NAc) and was recently proposed as a potential therapeutic target for schizophrenia. In the current study, we investigated the in vitro and in vivo pharmacologic activities of a nov …

发布时间：2024-07-12

• All

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/27017420All-Cause Mortality Attributable to Sitting Time: Analysis of …网页Assuming that the effect of sitting time on all-cause mortality risk is independent of physical activity, reducing sitting time plays an important role in active lifestyle promotion, which is an important aspect of premature mortality prevention worldwide.

发布时间：2024-07-12

• Forms

发布时间：2024-07-12

• Omalizumab

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/11270941Omalizumab - PubMed网页Omalizumab. Immunoglobulin E. * Omalizumab is a recombinant humanised monoclonal antibody which specifically binds to the C epsilon3 domain of immunoglobulin (Ig) E, the site of high-affinity IgE receptor binding. * Improvements in asthma symptoms and health-related quality-of-life, and a significant reduction in the frequency o ….

发布时间：2024-07-12